1887

Abstract

HPIV3 is a respiratory virus causing airway diseases, including pneumonia, croup, and bronchiolitis, during infancy and childhood. Currently there is no effective vaccine or anti-viral therapy for this virus. Studies have suggested that poor T cell proliferation following HPIV3 infection is responsible for impaired immunological memory associated with this virus. We have previously demonstrated that NK cells mediate regulation of T cell proliferation during HPIV3 infection. Here we add to these studies by demonstrating that the regulation of T cell proliferation during HPIV3 infection is mediated via NK receptors NKp44 and NKp46 and involves the surface glycoprotein haemagglutinin-neuraminidase but not the fusion protein of the virus. These studies extend our knowledge of the regulatory repertoire of NK cells and provide mechanistic insights which may explain reoccurring failures of vaccines against this virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001070
2018-06-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/6/763.html?itemId=/content/journal/jgv/10.1099/jgv.0.001070&mimeType=html&fmt=ahah

References

  1. Henrickson KJ. Parainfluenza viruses. ClinMicrobiolRev 2013; 16:1–8
    [Google Scholar]
  2. Lee MS, Greenberg DP, Yeh SH, Yogev R, Reisinger KS et al. Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants. J Infect Dis 2001; 184:909–913 [View Article][PubMed]
    [Google Scholar]
  3. Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest 2005; 115:1688–1698 [View Article][PubMed]
    [Google Scholar]
  4. Bloom HH, Johnson KM, Jacobsen R, Chanock RM. Recovery of parainfluenza viruses from adults with upper respiratory illness. Am J Epidemiol 1961; 74:50–59 [View Article]
    [Google Scholar]
  5. Plotnicky-Gilquin H, Cyblat D, Aubry JP, Delneste Y, Blaecke A et al. Differential effects of parainfluenza virus type 3 on human monocytes and dendritic cells. Virology 2001; 285:82–90 [View Article][PubMed]
    [Google Scholar]
  6. Sieg S, Muro-Cacho C, Robertson S, Huang Y, Kaplan D. Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3. Proc Natl Acad Sci USA 1994; 91:6293–6297 [View Article][PubMed]
    [Google Scholar]
  7. Noone CM, Paget E, Lewis EA, Loetscher MR, Newman RW et al. Natural killer cells regulate T-cell proliferation during human parainfluenza virus type 3 infection. J Virol 2008; 82:9299–9302 [View Article][PubMed]
    [Google Scholar]
  8. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol Today 2000; 21:228–234 [View Article][PubMed]
    [Google Scholar]
  9. Costello T, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci M et al. Defective expression and function of natural killer cell – triggering receptors in patients with acute myeloid leukemia; 2016; 993661–3668
  10. Glasner A, Isaacson B, Mandelboim O. Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé). Sci Rep 2016; 7:40944 [View Article]
    [Google Scholar]
  11. De Maria A, Ugolotti E, Rutjens E, Mazza S, Radic L et al. NKp44 expression, phylogenesis and function in non-human primate NK cells. Int Immunol 2009; 21:245–255 [View Article][PubMed]
    [Google Scholar]
  12. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999; 189:787–796 [View Article][PubMed]
    [Google Scholar]
  13. Wade M, Li Y-C M, Wahl G. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. Nat Rev Cancer 2013; 13:83–96 [Crossref]
    [Google Scholar]
  14. Noone C, Manahan E, Newman R, Johnson P. Artificially generated dendritic cells misdirect antiviral immune responses. J Leukoc Biol 2007; 81:952–956 [View Article][PubMed]
    [Google Scholar]
  15. Stark S, Watzl C. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells. Int Immunol 2006; 18:241–247 [View Article][PubMed]
    [Google Scholar]
  16. Nolte ENM, Almeida CR, Cohen NR, Nedvetzki S, Davis DM et al. Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication Brief report Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor g. Blood 2008; 109:670–673 [Crossref]
    [Google Scholar]
  17. Rydbeck R, Orvell C, Löve A, Norrby E. Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies. J Gen Virol 1986; 67:1531–1542 [View Article][PubMed]
    [Google Scholar]
  18. Biassoni R, Bottino C, Cantoni C, Moretta A. Human natural killer receptors and their ligands. Curr Protoc Immunol 2002; 46:14.10.1–14.10.23
    [Google Scholar]
  19. Mandelboim O, Porgador A. NKp46. Int J Biochem Cell Biol 2001; 33:1147–1150 [View Article][PubMed]
    [Google Scholar]
  20. Mclaughlin LP, Lang H, Williams E, Wright KE, Powell A et al. HHS public access. Cytotherapy 2016; 18:1515–1524 [Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001070
Loading
/content/journal/jgv/10.1099/jgv.0.001070
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error